Filter by: Subject

Filter by: Subject

Results Per Page:

SDG-03: Good health and well-being (60)
Positron emission tomography (PET) (39)
Positron emission tomography/computed tomography (PET/CT) (39)
Prostate cancer (26)
Theranostics (18)
Prostate-specific membrane antigen (PSMA) (17)
Nuclear medicine (15)
Tuberculosis (TB) (15)
Human immunodeficiency virus (HIV) (12)
Infection (11)
Coronavirus disease 2019 (COVID-19) (10)
COVID-19 pandemic (10)
Radiopharmaceuticals (10)
Molecular imaging (9)
South Africa (SA) (9)
Cancer (8)
PET/CT (8)
Prostate carcinoma (7)
Prostate specific membrane antigen (PSMA) (7)
SDG-09: Industry, innovation and infrastructure (7)
Radiomics (6)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (6)
Breast cancer (5)
Cervical cancer (5)
Computed tomography (CT) (5)
HIV infection (5)
Inflammation (5)
Metastatic castration-resistant prostate cancer (mCRPC) (5)
Oncology (5)
Radiochemistry (5)
Single-photon emission computed tomography (SPECT) (5)
Actinium-225 (4)
Africa (4)
Antimicrobial peptide (AMP) (4)
Diagnosis (4)
Fluorodeoxyglucose (FDG) (4)
Fluorodeoxyglucose positron emission tomography (FDG PET) (4)
Hypoxia (4)
Infection imaging (4)
Patients (4)
PSA response (4)
Single photon emission computed tomography (SPECT) (4)
Targeted alpha therapy (4)
Total lesion glycolysis (TLG) (4)
Zirconium-89 (4)
225Ac-PSMA-617 (3)
[18F]FDG PET/CT (3)
Angiogenesis (3)
Anti-tuberculous treatment (ATT) (3)
Bacteria (3)
Biochemical recurrence (BCR) (3)
Biodistribution (3)
Editorial (3)
Fibroblast activation protein (FAP) (3)
Fibroblast activation protein inhibitor (FAPI) (3)
Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) (3)
Glioblastoma (3)
Health sciences articles SDG-03 (3)
Immunohistochemistry (3)
Invasive fungal infection (IFI) (3)
Invasive fungal infections (3)
Magnetic resonance imaging (MRI) (3)
Metabolic parameters (3)
Metabolic tumor volume (MTV) (3)
Overall survival (OS) (3)
PET imaging (3)
Prostate-specific antigen (PSA) (3)
Quality control (3)
Radiolabeling (3)
Radioligand therapy (3)
Radionuclides (3)
Residual metabolic activity (RMA) (3)
SDG-04: Quality education (3)
SPECT (3)
SPECT/CT (3)
Targeted radionuclide therapy (3)
Ubiquicidin (3)
177Lu-PSMA (2)
18F-FDG (2)
18F-FDG PET/CT (2)